Collegium Pharmaceutical, Inc. (COLL) vs Alpha Teknova, Inc. (TKNO)

Collegium Pharmaceutical, Inc. and Alpha Teknova, Inc. are both Drug Manufacturers Specialty & Generic companies. Collegium Pharmaceutical, Inc. is the larger, with a market value of $737.1M against $498.8M — 1.5× the size. Alpha Teknova, Inc. has negative trailing earnings, so its P/E is not meaningful; Collegium Pharmaceutical, Inc. trades at 14.7×. Collegium Pharmaceutical, Inc. grew revenue faster over the last twelve months: 14.3% against 12.3%. Collegium Pharmaceutical, Inc. has the higher net margin (5.93% vs −38.4%) and the higher return on invested capital (7.85% vs −16.9%). Across the 19 metrics below, Collegium Pharmaceutical, Inc. leads on 14 and Alpha Teknova, Inc. on 5.

Valuation

Metric COLL TKNO Drug Manufacturers Specialty & Generic median
P/E 14.73 n/m 20.14
P/S 0.90 11.45 2.25
P/B 2.34 7.99 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA 4.29 n/m 12.29
EV/Sales 2.07 11.45 2.56
Earnings yield 6.79% (3.32%) (2.99%)
Free cash flow yield (5.46%) (1.47%) 0.00%

Profitability

Metric COLL TKNO Drug Manufacturers Specialty & Generic median
Gross margin 60.02% 34.60% 53.94%
Operating margin 19.48% (36.19%) 0.00%
Net margin 5.93% (38.37%) 0.00%
Free cash flow margin 40.62% (16.83%) 0.00%
Return on equity 17.61% (24.19%) (0.40%)
Return on assets 2.57% (16.25%) (3.32%)
Return on invested capital 7.85% (16.93%) 0.00%

Growth

Metric COLL TKNO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 14.31% 12.27% 10.01%
EPS growth (last fiscal year) (6.99%) 43.86% —
Revenue growth, 5-year CAGR 20.28% 5.30% 6.74%
Net income growth, 5-year CAGR 18.64% 0.00% 0.00%

Health

Metric COLL TKNO Drug Manufacturers Specialty & Generic median
Debt to equity 3.50 0.21 0.05
Current ratio 1.03 4.49 2.31
Net debt to EBITDA 1.00 0.75 0.85

Dividend

Metric COLL TKNO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric COLL TKNO Drug Manufacturers Specialty & Generic median
Market cap 737.06m 498.76m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack